Toni-Ann Citera

DOJ Updates Corporate Compliance Program Guidance With A Focus On AI And Emerging Technologies

Canadian Drug Importation May Undermine Intellectual Property Protection

California Supreme Court Will Review Novel Negligence Theory For Pharmaceutical Manufacturers

The Evolution Of Corporate Compliance Programs: Key Issues For Multinational Companies (Podcast)

FDA Proposes National Standards For Wholesale Drug Distributors And Third-Party Logistics Providers

Executive Order On Promoting Competition In The American Economy: A Focus On Patent And Drug Law To Reduce Health Care Spending

Recent Changes To The Anti-Kickback Statute's Personal Services Safe Harbor

White House Orders Attempt To Regulate Prescription Drug Prices

Third Circuit Rejects False Claims Act Theory That Anti-Kickback Violations "Taint" All Related Claims

False Claims Act's "Rigorous" Materiality Standard Enforced By Second Circuit